|
|
Volumn 98, Issue 3, 2001, Pages 235-236
|
|
Neuroprotection;Neuroprotektion
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM;
GABAPENTIN;
N METHYL DEXTRO ASPARTIC ACID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROTRANSMITTER;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRIMONIDINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
MEMANTINE;
NEUROPROTECTIVE AGENT;
QUINOXALINE DERIVATIVE;
APOPTOSIS;
EDITORIAL;
NERVOUS SYSTEM;
NEUROPROTECTION;
OXIDATION;
PATHOPHYSIOLOGY;
RETINA GANGLION CELL;
RETINA PIGMENT DEGENERATION;
RETINOPATHY;
ANIMAL;
CLINICAL TRIAL;
DISEASE MODEL;
DRUG EFFECT;
EYE DISEASE;
FORECASTING;
GLAUCOMA;
HUMAN;
OPTIC NEURITIS;
PHYSIOLOGY;
RETINA DISEASE;
VISUAL FIELD;
ADRENERGIC ALPHA-AGONISTS;
ANIMALS;
APOPTOSIS;
CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
DOPAMINE AGENTS;
EYE DISEASES;
FORECASTING;
GLAUCOMA;
HUMANS;
MEMANTINE;
NEUROPROTECTIVE AGENTS;
OPTIC NEURITIS;
QUINOXALINES;
RETINAL DISEASES;
VISUAL FIELDS;
|
|
EID: 0035086581
PISSN: 0941293X
EISSN: None
Source Type: Journal
DOI: 10.1007/s003470170154 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|